DENTI, VANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.062
AS - Asia 6.383
EU - Europa 5.445
SA - Sud America 729
Continente sconosciuto - Info sul continente non disponibili 544
AF - Africa 128
OC - Oceania 33
Totale 22.324
Nazione #
US - Stati Uniti d'America 8.597
IT - Italia 2.685
SG - Singapore 1.782
VN - Vietnam 1.693
CN - Cina 1.188
HK - Hong Kong 622
BR - Brasile 546
DE - Germania 515
RU - Federazione Russa 445
CA - Canada 333
SE - Svezia 313
IE - Irlanda 278
GB - Regno Unito 277
BD - Bangladesh 251
FR - Francia 197
IN - India 192
AT - Austria 139
NL - Olanda 118
KR - Corea 103
ES - Italia 83
JP - Giappone 78
FI - Finlandia 68
ID - Indonesia 67
AR - Argentina 66
UA - Ucraina 66
IQ - Iraq 63
PL - Polonia 59
TR - Turchia 57
CH - Svizzera 52
ZA - Sudafrica 48
MX - Messico 43
PK - Pakistan 41
TW - Taiwan 34
AU - Australia 33
EC - Ecuador 30
IR - Iran 30
DK - Danimarca 28
CO - Colombia 26
SA - Arabia Saudita 24
BE - Belgio 23
PH - Filippine 22
CR - Costa Rica 20
VE - Venezuela 20
MA - Marocco 18
MY - Malesia 17
LT - Lituania 15
JM - Giamaica 14
CL - Cile 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
IL - Israele 11
RO - Romania 11
TN - Tunisia 11
AZ - Azerbaigian 10
JO - Giordania 10
TH - Thailandia 10
KE - Kenya 9
NO - Norvegia 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
NI - Nicaragua 8
PY - Paraguay 8
ET - Etiopia 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
UY - Uruguay 7
BO - Bolivia 6
HU - Ungheria 6
PE - Perù 6
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
LV - Lettonia 5
NP - Nepal 5
PA - Panama 5
PS - Palestinian Territory 5
SC - Seychelles 5
AL - Albania 4
AM - Armenia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
LU - Lussemburgo 4
PR - Porto Rico 4
RS - Serbia 4
SV - El Salvador 4
BG - Bulgaria 3
HR - Croazia 3
KG - Kirghizistan 3
MN - Mongolia 3
MT - Malta 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BS - Bahamas 2
GA - Gabon 2
GE - Georgia 2
HT - Haiti 2
Totale 21.742
Città #
San Jose 1.050
Milan 1.008
Singapore 976
Ashburn 948
Ann Arbor 789
Hong Kong 592
Ho Chi Minh City 509
Hanoi 442
Dallas 316
Frankfurt am Main 315
Los Angeles 272
Dublin 270
Chandler 248
Council Bluffs 228
New York 209
Santa Clara 193
Wilmington 184
Toronto 182
Beijing 175
Fairfield 163
Rome 148
Hefei 141
Columbus 134
Chicago 129
Dearborn 113
Houston 103
Seoul 94
The Dalles 92
Vienna 92
Seattle 90
Shanghai 84
Phoenix 80
Woodbridge 78
São Paulo 72
Buffalo 71
Princeton 70
Orem 60
Da Nang 58
Lauterbourg 58
Cambridge 57
Haiphong 51
Kent 50
Turin 50
Tokyo 49
Moscow 48
Montreal 47
Boardman 44
Busto Arsizio 44
Brooklyn 42
Helsinki 42
London 42
Nanjing 42
Atlanta 40
Warsaw 40
Denver 38
Naples 38
Nuremberg 38
Ha Long 37
Sesto San Giovanni 37
Bologna 36
Bắc Ninh 36
Lissone 36
Jakarta 35
Manchester 35
Chennai 34
Munich 34
Washington 34
Madison 31
Biên Hòa 30
Boston 30
Dong Ket 30
Vũng Tàu 30
Zurich 30
Cagliari 28
Ninh Bình 28
Poplar 28
Quận Bình Thạnh 28
Stockholm 27
Hải Dương 25
Pune 25
Philadelphia 24
Quận Một 24
Thái Nguyên 24
Guangzhou 23
Newark 23
Baghdad 22
Fremont 22
Amsterdam 21
Leiden 21
Can Tho 20
Jacksonville 20
Austin 19
Basingstoke 19
San Diego 19
Dhaka 18
Figino 18
Johannesburg 18
New Delhi 18
San Francisco 18
Seregno 18
Totale 12.771
Nome #
Hyperoxic recovery impacts on metabolic adaptations induced by hypoxic exercise: A lipidomics approach 669
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 624
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 583
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 562
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 478
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 444
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 440
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 424
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 415
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 406
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 403
Hyperoxic recovery interferes with the metabolic imprint of hypoxic exercise 399
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 392
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 390
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 386
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 382
Development of multi-omic mass spectrometry imaging approaches to assist clinical investigations 381
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 376
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 375
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 369
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 331
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 311
A molecular imaging approach to individuate tumour infiltrating lymphocytes 309
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 301
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 287
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 286
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 283
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 281
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 263
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 262
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 261
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 258
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 256
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 253
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 240
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 237
UHPLC-TIMS-PASEF®-MS for Lipidomics: From Theory to Practice 235
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 231
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 230
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 228
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 224
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 220
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 216
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 216
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 214
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models 210
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 209
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 208
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 207
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 203
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 201
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 196
The interplay of NAD and hypoxic stress and its relevance for ageing 195
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 195
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 190
Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury 189
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 188
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 184
Co-registration of mass spectrometry and optical whole slide histology images for computational pathology 183
The impact of hyperoxia and hypoxic interval training on the plasma metabolome in skiing athletes 178
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 178
Enhanced Detection of Escherichia coli Lipids and Proteins Using Graphene-Polyglycerol Amine via Mass Spectrometry 178
Multi-omic and multimodal characterization of thyroid nodules: novel interplay between molecular and morphological features 175
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 169
High Intensity Concentric-Eccentric Exercise Under Hypoxia Changes the Blood Metabolome of Trained Athletes 168
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 166
Towards morpho-molecular learning in computational pathology 165
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 164
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 156
6-Aza-2-Thiothymine as a Novel Matrix for MALDI-MSI-Based Lipid Profiling in FFPE Samples 155
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 151
MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma 141
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 124
Improving the Annotation for Spatial Proteomics: A Computational Approach to Enhance Molecular Characterization of Thyroid Nodules 121
Understanding the metabolic role of trehalose in inducing autophagy 116
Visualization of Small Intact Proteins in Breast Cancer FFPE Tissue 115
The metabolic role of trehalose in autophagy induction in central nervous system 107
N-Glycan profiling from DBS using the power of timsTOF fleX 104
Exploring 6-Aza-2-Thiothymine as a MALDI-MSI Matrix for Lipid Mapping in FFPE Samples 103
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 95
EXPLORING THE MULTI-OMIC LANDSCAPE OF THYROID NODULES: A RETROSPECTIVE STUDY 91
Deceiving on central nervous system trehalose activity 88
SPATIAL MULTI-OMICS MALDI-MSI REVEALS MOLECULAR SIGNATURES ACROSS BREAST CANCER SUBTYPES 83
Advancing Thyroid Nodule Diagnosis: Integrating MALDI-MSI for Detailed Characterization of Indeterminate Lesions 74
Development and Validation of a nanoLC-TIMS-MS/MS Method for Structural Characterization of Plasma and DBS N-Glycans 69
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 66
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 64
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 64
MASS SPECTROMETRY APPLICATIONS FOR THE CHARACTERIZATION OF KRAS MUTATIONS IN LUNG CANCER 62
MULTI-OMIC AND MULTIMODAL CHARACTERIZATION OF THYROID NODULES: NOVEL INTERPLAY BETWEEN MOLECULAR AND MORPHOLOGICAL FEATURES 60
MULTI-OMIC AND MULTIMODAL CHARACTERIZATION OF THYROID NODULES: NOVEL INTERPLAY BETWEEN MOLECULAR AND MORPHOLOGICAL FEATURES 57
Spatial multi-omics insights into transplanted human thyroid organoid via spatial mass spectrometry imaging 56
A New Dimension of Thyroid Biology: Exploring Tissue Complexity through Spatial Multiomics 56
LC-MS/MS and SISCAPA Technology: A Novel Approach for Accurate Thyroglobulin Quantification Overcoming Antibody Interference 54
Advancing Thyroid Nodule Diagnosis: Integrating MALDI-MSI for Detailed Characterization of Indeterminate Lesions 53
Spatial Proteomic Analysis of KRAS-Mutant Lung Cancer 51
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 50
A novel application of ATT as a MALDI MS matrix for the imaging of tryptic peptides 42
MASS SPECTROMETRY APPLICATIONS FOR THE CHARACTERIZATION OF KRAS MUTATIONS IN LUNG CANCER 34
Comprehensive Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Tissue Guided by Mass Spectrometry-Imaging 32
Totale 22.324
Categoria #
all - tutte 63.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022599 0 0 0 125 52 72 7 42 31 49 98 123
2022/20231.164 146 258 137 106 43 159 15 76 87 17 61 59
2023/20241.085 47 35 45 82 91 284 208 42 58 25 59 109
2024/20253.115 91 182 143 104 340 155 216 124 382 490 374 514
2025/202611.065 1.607 828 835 1.231 922 415 1.390 470 739 1.040 683 905
2026/20272.909 758 617 1.424 110 0 0 0 0 0 0 0 0
Totale 22.324